Dr. Bryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1101 Madison St
Ste 301
Seattle, WA 98104Phone+1 206-505-1101
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1990 - 1993
Louisiana State University School of MedicineResidency, Internal Medicine, 1986 - 1990- Louisiana State University School of Medicine in New OrleansClass of 1986
Certifications & Licensure
WA State Medical License 1990 - 2025
LA State Medical License 1986 - 2017
Publications & Presentations
PubMed
- 84 citationsPhase Ib Trial of the Toll-like Receptor 8 Agonist, Motolimod (VTX-2337), Combined with Cetuximab in Patients with Recurrent or Metastatic SCCHN.Laura Q.M. Chow, Chihiro Morishima, Keith D. Eaton, Christina S. Baik, Bernardo H. L. Goulart
Clinical Cancer Research. 2017-05-15 - 30 citationsLate Stage Cancer Patients Remain Highly Responsive to Immune Activation by the Selective TLR8 Agonist Motolimod (VTX-2337)Gregory N. Dietsch, Tressa D. Randall, Raphael Gottardo, Donald W. Northfelt, Ramesh K. Ramanathan
Clinical Cancer Research. 2015-12-15
Press Mentions
ASCO ’22 Preview: Putting Patients FirstJune 1st, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
